Xian, China, June 23, 2021 (GLOBE NEWSWIRE) – Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading provider of bio-ingredient solutions in the natural fields, Health and Personal Care Industries, today announced the price of its initial binding public offering of 2,200,000 common shares, with a par value of $ 0.0001 per share (the “Shares”) at a public offering price of $ 5.00 per Share (the “Offer”), for an aggregate gross proceeds of $ 11.0 million, before the deduction of subscription discounts, commissions and other related expenses. In addition, BON has granted the underwriters a 45-day option to purchase up to 330,000 additional shares at the tender offer price, less the underwriting discount and commissions. The Shares are expected to begin trading on the Nasdaq Capital Market under the symbol “BON” on June 24, 2021. The Offer is expected to close on or around June 28, 2021, subject to the satisfaction of customary closing conditions.
The Company intends to use the proceeds for working capital, to expand its sales and distribution network, research and development and to expand its production capacity.
US Tiger Securities, Inc. and Newbridge Securities Corporation are acting as co-lead bookkeepers, and RF Lafferty & Co. Inc. act as co-lead bookkeepers.
The securities of the Company described above are offered pursuant to an effective registration statement on Form F-1 (SEC File No. 333-251182), which has been previously filed with the Securities and Exchange Commission (“SEC ) On May 14, 2021, subsequently amended and declared effective June 23, 2021, a copy of which has been filed with the SEC and is available on the SEC’s website at www.sec.gov. The Offer is being made only by means of such a prospectus.
This press release contains information on the current Offer of securities, and there can be no assurance that the Offer will be completed.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, and there may be no sale of such securities in any state or jurisdiction in which such an offer, solicitation or sale would be illegal. prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Bon Natural Life Limited
The Company is focused on the manufacture of personal care ingredients, such as scent compounds extracted from plants for perfume and fragrance manufacturers, natural health supplements such as powdered beverages and bioactive food ingredient products. mainly used as food additives and nutritional supplements by their customers. For more information, please visit the Company’s website at www.bnlus.com.
Safe Harbor Declaration
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding future plans, objectives, goals, strategies, events or performance, and assumptions underlying statements and other statements that are other than statements of historical fact. When the Company uses words such as “may”, “will”, “intention”, “should”, “believe”, “expect”, “anticipate”, “plan”, “estimate” or Similar phrases that do not relate solely to matters, it makes forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties which may cause actual results to differ materially from the expectations of the Company discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the objectives and strategies of the Company; the future business development of the Company; demand and acceptance of products and services; technological changes; economic conditions; the growth of the natural, health and personal care products market in China and other international markets that the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China and in the international markets that the Company intends to serve and the assumptions underlying or related to any of the aforementioned risks and other risks contained in reports filed by the Company with the SEC. For these and other reasons, investors are cautioned not to place undue reliance on any forward-looking statements contained in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company assumes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
For more information please contact: